Makers of drugs and devices are justifiably concerned about intellectual property theft by mainland China, but it has come to light that Beijing has extended its espionage tentacles into institutions handling research grants provided by the U.S. National Institutes of Health. NIH Director Francis Collins advised a Senate committee that the agency is working to suppress such intellectual property theft, but noted that for some of the institutions receiving those grants, "there was initially some surprise and even denial" about the problem, a state of disbelief that more than four dozen FBI investigations seem to have resolved.